# BloodRayne 2: Terminal Cut

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 1373550
- Developer: Terminal Reality
- Publisher: Ziggurat
- Released: 2020 · Genre: Action · List price: $14.99
- Deal grade: B (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $881 to $1.3k per month (mid $1.1k)
- Opportunity score: $2.3k/month at x2.10 dormancy multiplier
- Est. lifetime owners: 30.2k · Est. lifetime net revenue: $97.2k
- Review sentiment: 77% positive across 1216 reviews (1006 from Steam purchases)
- Review velocity: 13.7 reviews/month (6-month average)

## Why it's flagged

- Developer silent for 3.8 years
- Studio active elsewhere (3 titles tracked), so this one may welcome a partner
- Last build shipped 3.8 years ago
- Last discounted 0 months ago, 10 sales in the last 12 months
- Proven demand elasticity: x1.5 review velocity during past deep sales

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $2.0k |
| After VAT / sales tax (-13% blended) | $1.7k |
| After refunds (-9.5% median) | $1.6k |
| Net to developer (after Steam 30%) | $1.1k |

## Monthly review counts, oldest to newest (24 months)

6, 8, 8, 13, 16, 12, 8, 10, 6, 9, 17, 16, 11, 13, 13, 18, 27, 14, 15, 10, 14, 8, 19, 16

## Estimated acquisition range

$26.4k to $52.8k (2-4x the trailing net annuity of $13.2k/year). Same error range applies.

## Analyst notes (AI-assisted)

A 2020 remaster of the 2004 action game BloodRayne 2, published by Ziggurat and developed by Terminal Reality.

BloodRayne 2: Terminal Cut holds modest but steady residual revenue ($1,100/mo mid-estimate) on a tiny attach base of 30k lifetime units, with 77% positive sentiment from engaged fans. The franchise retains cult appeal and the Terminal Cut label suggests room for enhanced ports or collections, but the developer is inactive and gameplay friction is a recurring complaint. This is a watch for licensing or publishing partners considering vampire-action IP revival, not an acquisition target.

- Most realistic play: watch
- Risk (tech): Developer Terminal Reality listed as inactive; future patches or platform support will require external engineering.
- Risk (market): Narrow appeal to series loyalists; player reviews cite stress and precision-demand issues that limit mainstream crossover potential.
- Risk (other): Remaster of a 16-year-old title with minimal graphical improvement per reviews, leaving unclear value prop for new audiences on current platforms.

What players are asking for:
- BloodRayne 3 (franchise continuation)
- Improved difficulty balancing and accessibility options
- Enhanced visuals that justify the Terminal Cut label
- Costume/cosmetic parity with modern action titles

Suggested first moves:
1. Audit Ziggurat's publishing arrangement and IP ownership structure; clarify whether BloodRayne franchise rights allow derivative works or new installments.
2. Survey broader vampire-action market (competitor price, player base size, monetization models) to assess realistic scale of a franchise revival or new title.
3. Conduct light UX audit on control/difficulty systems to identify whether moderate tuning could expand the addressable audience beyond series veterans.

Generated 2026-08-20 from public signals and player reviews. Directional, not diligence.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/1373550
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.